The ACSR Democratizes Access To Pathology Data With Proscia, Advancing Breakthroughs For HIV Cancer Patients
Summary
"We are fortunate to have a growing library of rare and valuable biospecimens that have contributed to the fight against cancer in PLWH," said Dr. Paige Bracci, UCSF Professor of Epidemiology and Biostatistics, and Director of the ACSRs Informatics program. Since selecting Concentriq for Research, the ACSR has reduced the time it takes to provide investigators with pathology data from days to hours. In addition, this approach allows for conservation and increased sustainability of rare and exhaustible tissue specimens to a large number of individual researchers. The ACSRs mission is to acquire, store, and equitably distribute these tissues and biological fluids along with associated clinical data to investigators conducting HIV related research. Its Concentriq enterprise pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision care.